132 related articles for article (PubMed ID: 27000164)
21. Pharmacists as health educators and risk communicators in the early detection of prostate cancer.
Odedina FT; Warrick C; Vilme H; Young S
Res Social Adm Pharm; 2008 Mar; 4(1):59-66. PubMed ID: 18342823
[TBL] [Abstract][Full Text] [Related]
22. Pharmacy-perceived barriers to cancer pain control: results of the North Carolina Cancer Pain Initiative Pharmacist Survey.
Krick SE; Lindley CM; Bennett M
Ann Pharmacother; 1994; 28(7-8):857-62. PubMed ID: 7949500
[TBL] [Abstract][Full Text] [Related]
23. Attitudes of Finnish community pharmacists toward concordance.
Kansanaho HM; Puumalainen II; Varunki MM; Airaksinen MS; Aslani P
Ann Pharmacother; 2004 Nov; 38(11):1946-53. PubMed ID: 15466906
[TBL] [Abstract][Full Text] [Related]
24. How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants?
Hamedi N; da Costa FA; Horne R; Levitan M; Begley A; Antoniou S
Int J Clin Pharm; 2017 Dec; 39(6):1273-1281. PubMed ID: 28875370
[TBL] [Abstract][Full Text] [Related]
25. Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand.
Saengcharoen W; Lerkiatbundit S
Headache; 2013 Oct; 53(9):1451-63. PubMed ID: 23808927
[TBL] [Abstract][Full Text] [Related]
26. A comparison of patients' and pharmacists' satisfaction with medication counseling provided by community pharmacies: a cross-sectional survey.
Yang S; Kim D; Choi HJ; Chang MJ
BMC Health Serv Res; 2016 Apr; 16():131. PubMed ID: 27080704
[TBL] [Abstract][Full Text] [Related]
27. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
Res Social Adm Pharm; 2011 Dec; 7(4):369-82. PubMed ID: 21272531
[TBL] [Abstract][Full Text] [Related]
28. Patient perspective of medication information desired and barriers to asking pharmacists questions.
Krueger JL; Hermansen-Kobulnicky CJ
J Am Pharm Assoc (2003); 2011; 51(4):510-9. PubMed ID: 21752774
[TBL] [Abstract][Full Text] [Related]
29. Theoretical exploration of Tennessee community pharmacists' perceptions regarding opioid pain reliever abuse communication.
Hagemeier NE; Murawski MM; Lopez NC; Alamian A; Pack RP
Res Social Adm Pharm; 2014; 10(3):562-75. PubMed ID: 23981913
[TBL] [Abstract][Full Text] [Related]
30. Pharmacists' knowledge and attitudes toward herbal medicine.
Chang ZG; Kennedy DT; Holdford DA; Small RE
Ann Pharmacother; 2000 Jun; 34(6):710-5. PubMed ID: 10860130
[TBL] [Abstract][Full Text] [Related]
31. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
Chan A; Tan SH; Wong CM; Yap KY; Ko Y
Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
[TBL] [Abstract][Full Text] [Related]
32. Activities and perceptions of pharmacists providing tobacco control services in community pharmacy in Thailand.
Thananithisak C; Nimpitakpong P; Chaiyakunapruk N
Nicotine Tob Res; 2008 May; 10(5):921-5. PubMed ID: 18569768
[TBL] [Abstract][Full Text] [Related]
33. Texas pharmacists' opinions about and plans for provision of medication therapy management services.
Moczygemba LR; Barner JC; Roberson K
J Am Pharm Assoc (2003); 2008; 48(1):38-45. PubMed ID: 18192129
[TBL] [Abstract][Full Text] [Related]
34. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
Lee KK; Chan TY; Raymond K; Critchley JA
Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
[TBL] [Abstract][Full Text] [Related]
35. Are pharmacists ready for a greater role in travel health? An evaluation of the knowledge and confidence in providing travel health advice of pharmacists practicing in a community pharmacy chain in Alberta, Canada.
Bascom CS; Rosenthal MM; Houle SK
J Travel Med; 2015; 22(2):99-104. PubMed ID: 25410438
[TBL] [Abstract][Full Text] [Related]
36. Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.
Gavaza P; Brown CM; Lawson KA; Rascati KL; Steinhardt M; Wilson JP
J Am Pharm Assoc (2003); 2012; 52(5):e109-12. PubMed ID: 23023857
[TBL] [Abstract][Full Text] [Related]
37. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease.
O'Loughlin J; Masson P; Déry V; Fagnan D
Prev Med; 1999 Mar; 28(3):324-31. PubMed ID: 10072752
[TBL] [Abstract][Full Text] [Related]
38. Community pharmacists' knowledge, beliefs and attitudes towards immunization in Quebec.
Valiquette JR; Bédard P
Can J Public Health; 2015 Mar; 106(3):e89-94. PubMed ID: 26125247
[TBL] [Abstract][Full Text] [Related]
39. Food for thought: Can community pharmacists help patients living in food deserts?
Schooley TR; DiPietro Mager NA
J Am Pharm Assoc (2003); 2022; 62(4):1369-1373. PubMed ID: 35063368
[TBL] [Abstract][Full Text] [Related]
40. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
Blake KB; Madhavan SS
Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
